Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach Publisher

Azodi MZ¹ ; Arjmand B^{2, 3} ; Zali A⁴ ; Razzaghi M⁵

Show Affiliations

1. Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
4. Functional Neurosurgery Research Center, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5. Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Gastroenterology and Hepatology from Bed to Bench Published:2020

Abstract

Aim: Introducing possible diagnostic and therapeutic biomarker candidates via the identification of chief dysregulated proteins in COVID-19 patients is the aim of this study. Background: Molecular studies, especially proteomics, can be considered as suitable approaches for discovering the hidden aspect of the disease. Methods: Differentially expressed proteins (DEPs) of three patients with demonstrated severe condition (S-COVID-19) were compared to healthy cases by a proteomics study. Cytoscape software and STRING database were used to construct the protein-protein interaction (PPI) network. The central DEPs were identified through topological analysis of the network. ClueGO+CluePedia were applied to find the biological processes related to the central nodes. MCODE molecular complex detection (MCODE) was used to discover protein complexes. Results: A total of 242 DEPs from among 256 query ones were included in the network. Centrality analysis of the network assigned 16 hub-bottlenecks, nine of which were presented in the highest-scored protein complex. Ten protein complexes were determined. APOA1 was identified as the protein complex seed, and APP, EGF, and C3 were the top hub-bottlenecks of the network. The results specify that up-regulation of C3 and down-regulation of APOA1 in urine play a role in the stiffness in respiration and, accordingly, the severity of COVID-19. Moreover, dysregulation of APP and APOA1 could both contribute to the possible adverse effects of COVID-19 on the nervous system. Conclusion: The introduced central proteins of the S-COVID-19 interaction network, particularly APOA1, can be considered as diagnostic and therapeutic targets related to the coronavirus disease after being approved with complementary studies. © 2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.

Related Docs

View other Related Docs

1. Uncovering Systemic Lupus Erythematosus Candidate Proteomic Biomarkers: A Bioinformatics Approach, Journal of Cellular and Molecular Anesthesia (2022)

2. Association Between Cardiometabolic Risk Factors and Covid-19 Susceptibility, Severity and Mortality: A Review, Journal of Diabetes and Metabolic Disorders (2021)

3. Complement Inhibition: A Possible Therapeutic Approach in the Fight Against Covid-19, Reviews in Medical Virology (2022)

4. Serum Proteomic Profiling of Obsessive-Compulsive Disorder, Washing Subtype: A Preliminary Study, Basic and Clinical Neuroscience (2017)

5. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

6. Predicting Radioresistant Biomarkers in Nasopharyngeal Carcinoma Patients Via Protein-Protein Interaction Network Analysis, Journal of Lasers in Medical Sciences (2021)

7. Evaluation of Anticancer Effect of Ghost Pepper: A Bioinformatics Assessment, Research Journal of Pharmacognosy (2021)

8. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)

Experts (# of related papers)

View all Related Experts

Babak Arjmand (8)

Nima Rezaei (2)

Other Related Docs

9. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)

10. Identification of Joint Gene Players Implicated in the Pathogenesis of Htlv-1 and Blv Through a Comprehensive System Biology Analysis, Microbial Pathogenesis (2021)

11. Contradictory Effects of 6-Shogaol on the Human Cervical Cancer Cell Line Hela Through Network Analysis, Research Journal of Pharmacognosy (2022)

12. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)

13. Complement System As the Potential Therapeutic Target in the Management of Covid-19 Patients, Trends in Immunotherapy (2022)

14. Protein-Protein Interaction Network Could Reveal the Relationship Between the Breast and Colon Cancer, Gastroenterology and Hepatology from Bed to Bench (2015)

15. Expression Analysis of Long Non-Coding Rnas Related With Foxm1, Gata3, Foxa1 and Esr1 in Breast Tissues, Frontiers in Oncology (2021)

16. Cancer Chemo-Preventive Effects of Red Propolis: A System Biology Approach, Research Journal of Pharmacognosy (2023)

17. Vitamin D and Covid-19: From Potential Therapeutic Effects to Unanswered Questions, Reviews in Medical Virology (2021)

18. Platelet and Haemostasis Are the Main Targets in Severe Cases of Covid-19 Infection; a System Biology Study, Archives of Academic Emergency Medicine (2021)

19. Circular Rna-Associated Cerna Network Involved in Hif-1 Signalling in Triple-Negative Breast Cancer: Circ_0047303 As a Potential Key Regulator, Journal of Cellular and Molecular Medicine (2021)

20. Coagulopathy and Thromboembolic Events a Pathogenic Mechanism of Covid-19 Associated With Mortality: An Updated Review, Journal of Clinical Laboratory Analysis (2023)

21. The Risk Factors Associated With Covid-19-Related Death Among Patients With End‐Stage Renal Disease, BMC Nephrology (2021)

22. Systems Biomedicine of Rabies Delineates the Affected Signaling Pathways, Frontiers in Microbiology (2016)

23. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)

24. A Review of Pathophysiology, Mortality, Risk Factors and Protective Measures of Acute Kidney Injury in Covid-19 Patients With Underlying Kidney Disease and Kidney Transplant Recipients, Journal of Nephropathology (2022)

25. Biochemical Parameters and Pathogenesis of Sars-Cov-2 Infection in Vital Organs: Covid-19 Outbreak in Iran, New Microbes and New Infections (2020)

26. Association of Microbiota-Derived Propionic Acid and Alzheimer’S Disease; Bioinformatics Analysis, Journal of Diabetes and Metabolic Disorders (2020)

27. Deciphering the Similarities and Disparities of Molecular Mechanisms Behind Respiratory Epithelium Response to Hcov-229E and Sars-Cov-2 and Drug Repurposing, a Systems Biology Approach, DARU# Journal of Pharmaceutical Sciences (2024)

28. Bioinformatics Analysis of Hsp90 in Amniotic Fluid and Amniotic Membrane Cells As a Potential Anticancer Drug Target, Journal of Global Pharma Technology (2016)

29. Meta-Analysis of Gene Expression Profiles in Acute Promyelocytic Leukemia Reveals Involved Pathways, International Journal of Hematology-Oncology and Stem Cell Research (2017)

30. A Systems Medicine Approach for Finding Target Proteins Affecting Treatment Outcomes in Patients With Non-Hodgkin Lymphoma, PLoS ONE (2017)

31. Sars-Cov-2 Nucleocapsid: Biological Functions and Implication for Disease Diagnosis and Vaccine Design, Reviews in Medical Virology (2023)

32. Pathophysiological Clues to How the Emergent Sars-Cov-2 Can Potentially Increase the Susceptibility to Neurodegeneration, Molecular Neurobiology (2021)

33. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)

34. Correlation of Clinical, Laboratory, and Short-Term Outcomes of Immunocompromised and Immunocompetent Covid-19 Patients With Semi-Quantitative Chest Ct Score Findings: A Case-Control Study, Immunity# Inflammation and Disease (2024)

35. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)

36. Covid-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions, Frontiers in Cell and Developmental Biology (2021)

37. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)

38. Digging Deep Into Molecular Pathways: Investigating the Effects of 9S-Hod on Leukemia Cells Using a Systems Biology Approach, Iranian Journal of Blood and Cancer (2023)

39. Identification and Prediction of Common Molecular Culprits Between Psoriasis and Melanoma Via Bioinformatical Analysis, Gene Reports (2021)

40. Covid-19 in Patients With Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization, Rheumatology and Therapy (2023)

41. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)

42. The Role of Lovastatin in the Attenuation of Covid-19, International Immunopharmacology (2021)

43. Association Between Serum Inflammatory Parameters and the Disease Severity in Covid-19 Patients, Journal of Clinical Laboratory Analysis (2022)

Style	Citing Format
MLA	Azodi MZ, et al.. "Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach." Gastroenterology and Hepatology from Bed to Bench, vol. 13, no. 4, 2020, pp. 367-373.
APA	Azodi MZ, Arjmand B, Zali A, Razzaghi M (2020). Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach. Gastroenterology and Hepatology from Bed to Bench, 13(4), 367-373.
Chicago	Azodi MZ, Arjmand B, Zali A, Razzaghi M. "Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach." Gastroenterology and Hepatology from Bed to Bench 13, no. 4 (2020): 367-373.
Harvard	Azodi MZ et al. (2020) 'Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach', Gastroenterology and Hepatology from Bed to Bench, 13(4), pp. 367-373.
Vancouver	Azodi MZ, Arjmand B, Zali A, Razzaghi M. Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach. Gastroenterology and Hepatology from Bed to Bench. 2020;13(4):367-373.
BibTex	@article{ author = {Azodi MZ and Arjmand B and Zali A and Razzaghi M}, title = {Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach}, journal = {Gastroenterology and Hepatology from Bed to Bench}, volume = {13}, number = {4}, pages = {367-373}, year = {2020} }
RIS	TY - JOUR AU - Azodi MZ AU - Arjmand B AU - Zali A AU - Razzaghi M TI - Introducing Apoa1 As a Key Protein in Covid-19 Infection: A Bioinformatics Approach JO - Gastroenterology and Hepatology from Bed to Bench VL - 13 IS - 4 SP - 367 EP - 373 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract